Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58


Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment.

Arasada RR, Carpenter G.

J Biol Chem. 2005 Sep 2;280(35):30783-7. Epub 2005 Jun 27.


Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH.

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9176-81. Epub 2005 Jun 20.


ERBB receptors and cancer: the complexity of targeted inhibitors.

Hynes NE, Lane HA.

Nat Rev Cancer. 2005 May;5(5):341-54. Review. Erratum in: Nat Rev Cancer. 2005 Jul;5(7):580.


Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.

Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, Cheang M, Turbin D, Gelmon K, Huntsman DG.

Cancer. 2005 May 1;103(9):1770-7.


Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.

Vidal GA, Naresh A, Marrero L, Jones FE.

J Biol Chem. 2005 May 20;280(20):19777-83. Epub 2005 Mar 3.


Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Sunpaweravong P, Sunpaweravong S, Puttawibul P, Mitarnun W, Zeng C, Barón AE, Franklin W, Said S, Varella-Garcia M.

J Cancer Res Clin Oncol. 2005 Feb;131(2):111-9. Epub 2004 Oct 19.


A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

Wang RH, Yu H, Deng CX.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17108-13. Epub 2004 Nov 24.


The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.

Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE.

J Cell Biol. 2004 Nov 8;167(3):469-78.


Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS.

Sgagias MK, Wagner KU, Hamik B, Stoeger S, Spieker R, Huber LJ, Chodosh LA, Cowan KH.

Cell Cycle. 2004 Nov;3(11):1451-6. Epub 2004 Nov 8.


Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JF, Nicholson RI, Ellis IO.

Br J Cancer. 2004 Oct 18;91(8):1532-42.


Genetic pathways to glioblastoma: a population-based study.

Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.

Cancer Res. 2004 Oct 1;64(19):6892-9.


Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling.

Tovey SM, Witton CJ, Bartlett JM, Stanton PD, Reeves JR, Cooke TG.

Breast Cancer Res. 2004;6(3):R246-51. Epub 2004 Mar 23.


Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level.

Omerovic J, Puggioni EM, Napoletano S, Visco V, Fraioli R, Frati L, Gulino A, Alimandi M.

Exp Cell Res. 2004 Apr 1;294(2):469-79.


ErbB receptors: directing key signaling networks throughout life.

Holbro T, Hynes NE.

Annu Rev Pharmacol Toxicol. 2004;44:195-217. Review.


Cyclin B1 and CDK1: nuclear localization and upstream regulators.

Porter LA, Donoghue DJ.

Prog Cell Cycle Res. 2003;5:335-47. Review.


Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.

Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE.

Development. 2003 Nov;130(21):5257-68. Epub 2003 Sep 3.


The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.

Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, Hynes NE.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8. Epub 2003 Jul 9.


Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.

Witton CJ, Reeves JR, Going JJ, Cooke TG, Bartlett JM.

J Pathol. 2003 Jul;200(3):290-7.


Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality.

Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8281-6. Epub 2003 Jun 24.

Supplemental Content

Support Center